Cryoport announces Q4 2025 earnings call

Cryoport, Inc. held its fourth quarter and full year 2025 earnings conference call on March 3, 2026. The call featured company executives and analysts discussing financial performance. Forward-looking statements were highlighted with standard disclaimers.

On March 3, 2026, at 5:00 PM EST, Cryoport, Inc. (CYRX) conducted its Q4 2025 earnings conference call. The session was hosted by Todd Fromer and included key company participants: Jerrell Shelton, Chairman, President, and CEO; Mark W. Sawicki, Senior VP and Chief Scientific Officer; Robert Stefanovich, Senior VP, CFO, Treasurer, and Chief Administrative Officer; and Thomas Heinzen, Vice President of Corporate Development and Investor Relations.

Analysts from various firms joined the call, including Todd Fromer from Kanan, Corbin, Schupak & Aronow, Inc.; Puneet Souda from Leerink Partners LLC; Anna Snopkowski from KeyBanc Capital Markets Inc.; Subhalaxmi Nambi from Guggenheim Securities, LLC; David Saxon from Needham & Company, LLC; Steven Etoch from Stephens Inc.; and David Larsen from BTIG, LLC.

The operator opened the call, noting it was being recorded and providing instructions for participants. Todd Fromer then reminded listeners of forward-looking statements, stating: 'All statements that address our operating performance, events or developments that we expect or anticipate occurring in the future are forward-looking statements.' He emphasized that these are based on management's beliefs and subject to risks, advising against undue reliance and noting no obligation to update except as required by law.

The call aimed to cover Cryoport's financial results for the quarter and year ending in 2025, though specific details on performance were not included in the initial proceedings.

관련 기사

Pacira BioSciences, Inc. conducted its fourth quarter and full year 2025 earnings conference call on February 26, 2026. The call featured company executives discussing financial results. Participants included analysts from major financial firms.

AI에 의해 보고됨

ImmunityBio, Inc. conducted its full year 2025 earnings conference call on March 3, 2026, at 4:30 PM EST. The call featured company leaders and analysts, with a standard disclaimer on forward-looking statements. A replay is available on the company's investor relations website.

CCC Intelligent Solutions Holdings Inc. conducted its fourth quarter and full year 2025 earnings call on February 24, 2026. The session featured company executives discussing financial results announced earlier that day. Analysts from major financial firms participated in the conference.

AI에 의해 보고됨

Aixtron SE has published a slide deck for its 2025 fourth-quarter earnings call. The materials were made available on Seeking Alpha on February 26, 2026. This release accompanies the company's financial results discussion.

2026년 03월 04일 22시 14분

Okta holds Q4 2026 earnings call on March 4

2026년 03월 04일 15시 18분

Veeva Systems holds Q4 2026 earnings call

2026년 03월 02일 22시 08분

Quantum Computing Inc. holds Q4 2025 earnings call

2026년 03월 02일 17시 37분

Senseonics Holdings holds Q4 2025 earnings call

2026년 02월 26일 15시 06분

Cars.com Inc. reports Q4 2025 earnings on February 26

2026년 02월 26일 05시 33분

Clover Health conducts Q4 2025 earnings call

2026년 02월 25일 06시 06분

Sarepta Therapeutics holds Q4 2025 earnings call

2026년 02월 25일 04시 59분

Exzeo Group conducts Q4 2025 earnings call

2026년 02월 24일 09시 48분

First Solar holds Q4 2025 earnings call

2026년 02월 24일 03시 36분

CAVA Group hosts Q4 2025 earnings conference call

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부